3
Shared Docs
3
Same-Page
3 / 3
Mentions
ust 25, 2016 at 9:35:43 AM EDT To: Richard Kahn Rich, With yesterday's weakness in healthcare on pric
ions; we are reiterating our Buy recommendation on TEVA today and view the pullback as a buying opportunity. AGN A Pfd: $861.00 (6.4% strip yield) TEVVF Pfd: $883.25 (8.1% strip yield) EFTA00820341 With TEVA confirming the loss on 2 of its 5 Copaxone patents from yesterday's IPR decisions & MYL confir
ust 25, 2016 at 9:35:43 AM EDT To: Richard Kahn Rich, With yesterday's weakness in healthcare on pric
eiterating our Buy recommendation on TEVA today and view the pullback as a buying opportunity. AGN A Pfd: $861.00 (6.4% strip yield) EFTA00820350 TEVVF Pfd: $883.25 (8.1% strip yield) With TEVA confirming the loss on 2 of its 5 Copaxone patents from yesterday's IPR decisions & MYL confirming that the t
25, 2016 at 9:35:43 AM EDT To: Richard Kahn c > Rich, With yesterday's weakness in healthcare on pric
ons; we are reiterating our Buy recommendation on TEVA today and view the pullback as a buying opportunity. AGN A Pfd: $861.00 (6.4% strip yield) TEVVF Pfd: $883.25 (8.1% strip yield) With TEVA confirming the loss on 2 of its 5 Copaxone patents from yesterday's IPR decisions & MYL confirming that the t
Entities connected to both Marc Rich and TEVVF Pfd

Jeffrey Epstein
PERSON
Richard Kahn
PERSONAmanda
PERSONPierce, Fenner & Smith Incorporated
ORGANIZATIONAmanda Ens
PERSONReddy
LOCATIONDaniel Lundquist
PERSONSector Specialist Sales
ORGANIZATIONSumant
ORGANIZATIONCopaxone
ORGANIZATION
Mylan
ORGANIZATIONCopaxone 3TW
ORGANIZATIONHealthcare Specialist Sales
ORGANIZATIONSandoz/NVS
ORGANIZATIONMYL & MNTA
ORGANIZATIONEpiPen
ORGANIZATIONMYL Note
ORGANIZATIONCopaxone 3TW Litigation
ORGANIZATIONMNTA/Sandoz
ORGANIZATIONSynthon/Pfizer
ORGANIZATION